Nature Reviews Drug Discovery
Volume 20 Issue 10, October 2021
Comment | 27 May 2021
Envisioning an actionable research agenda to facilitate repurposing of off-patent drugs
Repurposing off-patent drugs has long been proposed as a cost-effective and efficient strategy to develop new treatments, but its potential has not been realized. Here, we highlight some of the barriers that underlie this lack of progress and discuss potential strategies to address them.
Christopher P. Austin, Bobbie Ann Mount, Christine M. Colvis